NIH grants $7.5 million for researchers to develop novel compounds in treating nicotine addiction
So our government is extending a helping hand to help BP develop promising smoking cessation products. We're trying to generate around $70k to do an indoor air quality study, IVAQS, with donations and raffles from people that have found, first hand, products that work on PEOPLE rather than rats. Wouldn't it be wonderful if the CDC took that $7.5 to do the same for this "promising technology"?
emphasis mineThis consortium grant is a competitive renewal of a previous award to Markou, in collaboration with Novartis, when her laboratory was located at Scripps Research. Chemists at Novartis involved in the previous phase of the program discovered a number of small-molecule modulators of the GABAB receptor. Further study resulted in the development of the first highly selective positive modulators for GABAB receptors. Subsequently, work in the Markou laboratory showed that these compounds had desirable effects on nicotine dependence in animal models, while offering a better side-effect profile than other alternatives under study (full agonists at the same receptors).
emphasis mine"This is not a typical individual investigator-driven science grant," Griffin said. "It's really a highly integrated and collaborative research program to discover innovative drug candidates. In this particular program to discover novel modulators of GABAB, the Scripps Florida team took on the translational role of a large pharmaceutical company. We are providing the framework and support to discover potent and functionally selective GABAB modulators that are efficacious in animal models of tobacco addiction. This project is very exciting and very energizing."
So our government is extending a helping hand to help BP develop promising smoking cessation products. We're trying to generate around $70k to do an indoor air quality study, IVAQS, with donations and raffles from people that have found, first hand, products that work on PEOPLE rather than rats. Wouldn't it be wonderful if the CDC took that $7.5 to do the same for this "promising technology"?